Market Place
Sourcing Support
YolTech To Start Trial For Gene Therapy YOLT-204 In ?-Thalassemia
22 Jan 2025 //
PR NEWSWIRE
YolTech Completes Dose Escalation Phase of YOLT-201 for ATTR
21 Dec 2024 //
PR NEWSWIRE
YolTech Sells China Rights Of Cholesterol Gene Editing Therapy To Salubris
27 Aug 2024 //
FIERCE BIOTECH
YolTech Therapeutics Doses First Patient In YOLT-203 IIT For PH1
22 Aug 2024 //
PR NEWSWIRE
First Patient Dosed in Phase I Clinical Trial of YOLT-201
11 Jul 2024 //
PR NEWSWIRE
First Patient Dosed in Clinical Trial of YOLT-101 for the Treatment of FH
02 Apr 2024 //
PR NEWSWIRE
YolTech Thera to Participate in 2024 Cell & Gene Meeting on the Mediterranean
27 Mar 2024 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.